Leisure Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LACQ and buy or sell other stocks, ETFs, and their options commission-free!About LACQ
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses.
CEOD. Lynn Kirkpatrick, PhD
CEOD. Lynn Kirkpatrick, PhD
Employees9
Employees9
HeadquartersLa Jolla, California
HeadquartersLa Jolla, California
Founded2003
Founded2003
Employees9
Employees9
LACQ Key Statistics
Market cap23.83M
Market cap23.83M
Price-Earnings ratio-0.36
Price-Earnings ratio-0.36
Dividend yield—
Dividend yield—
Average volume36.73K
Average volume36.73K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$14.67
52 Week high$14.67
52 Week low$1.62
52 Week low$1.62
People also own
Based on the portfolios of people who own LACQ. This list is generated using Robinhood data, and it’s not a recommendation.